Repair
Cibinetide (ARA-290)
ARA-290 / Cibinetide
- Peptide length
- 11 amino acids
Nonerythropoietic peptide analog
Research contextHuman studies exist
Read the linked studies for their methods and limitations.
An erythropoietin-derived peptide studied in small human trials, including sarcoidosis-associated small-fiber neuropathy.
- Family
- Erythropoietin-derived analog
- Research frame
- Proposed innate repair receptor
- Molecular format
- Nonerythropoietic peptide analog
Read the evidence
The cited trial found changes in nerve-fiber measures; the reported pain comparison did not reach conventional statistical significance. A surrogate change is not the same as proven symptom benefit.
Resolve the identity
Distinguish cibinetide from erythropoietin. Regulatory designations, if present, are not marketing approvals.